Literature DB >> 8749040

Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats.

P Popoli1, P Betto, R Reggio, G Ricciarello.   

Abstract

The influence of CGS 21680, an adenosine A2A receptor agonist, on striatal glutamate extracellular levels was tested in a microdialysis study in rats. CGS 21680 (10 mu M), infused intrastriatally through the microdialysis probe, greatly enhanced glutamate extracellular levels. These results show that striatal adenosine A2A receptors are involved in the regulation of striatal glutamate extracellular levels. They also suggest that adenosine A2A receptor antagonists may possess neuroprotective effects in models of striatal excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8749040     DOI: 10.1016/0014-2999(95)00679-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  46 in total

1.  A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice.

Authors:  J F Chen; Z Huang; J Ma; J Zhu; R Moratalla; D Standaert; M A Moskowitz; J S Fink; M A Schwarzschild
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

2.  Adenosine inhibition via A(1) receptor of N-type Ca(2+) current and peptide release from isolated neurohypophysial terminals of the rat.

Authors:  Gang Wang; Govindan Dayanithi; Edward E Custer; José R Lemos
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

3.  Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release.

Authors:  M Okada; D J Nutt; T Murakami; G Zhu; A Kamata; Y Kawata; S Kaneko
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

Review 4.  Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Authors:  K Fuxe; D Marcellino; D O Borroto-Escuela; M Guescini; V Fernández-Dueñas; S Tanganelli; A Rivera; F Ciruela; L F Agnati
Journal:  CNS Neurosci Ther       Date:  2010-03-16       Impact factor: 5.243

5.  Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.

Authors:  Jordi Bové; Jordi Serrats; Guadalupe Mengod; Roser Cortés; Eduardo Tolosa; Concepció Marin
Journal:  Exp Brain Res       Date:  2005-06-21       Impact factor: 1.972

6.  Adenosine A(1) receptor: Functional receptor-receptor interactions in the brain.

Authors:  Kathrin Sichardt; Karen Nieber
Journal:  Purinergic Signal       Date:  2007-09-05       Impact factor: 3.765

Review 7.  Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor field.

Authors:  Kjell Fuxe; Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Miklós Palkovits; Alexander O Tarakanov; Francisco Ciruela; Luigi F Agnati
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

Review 8.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

9.  Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration.

Authors:  Anil Kachroo; Michael C Irizarry; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2010-02-24       Impact factor: 5.330

10.  Functional histamine H3 and adenosine A2A receptor heteromers in recombinant cells and rat striatum.

Authors:  Ricardo Márquez-Gómez; Meridith T Robins; Citlaly Gutiérrez-Rodelo; Juan-Manuel Arias; Jesús-Alberto Olivares-Reyes; Richard M van Rijn; José-Antonio Arias-Montaño
Journal:  Pharmacol Res       Date:  2017-12-05       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.